Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel

PURPOSE: Patients with neuroblastoma in molecular remission remain at considerable risk for disease recurrence. Studies have found that neuroblastoma tissue contains adrenergic (ADRN) and mesenchymal (MES) cells; the latter express low levels of commonly used markers for minimal residual disease (MR...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCO Precis Oncol
Autors principals: van Wezel, Esther M., van Zogchel, Lieke M.J., van Wijk, Jalenka, Timmerman, Ilse, Vo, Ngoc-Kim, Zappeij-Kannegieter, Lily, deCarolis, Boris, Simon, Thorsten, van Noesel, Max M., Molenaar, Jan J., van Groningen, Tim, Versteeg, Rogier, Caron, Huib N., van der Schoot, C. Ellen, Koster, Jan, van Nes, Johan, Tytgat, Godelieve A.M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2019
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8133311/
https://ncbi.nlm.nih.gov/pubmed/34036221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00413
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars